Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Go back to Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update| Labranche & Co (NASDAQ: LAB) | Delayed: 0.91 +0.04 (4.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $4.47 | |||
| Open | $0.85 | 52 Week Low | $3.02 | |||
| Day High | $0.93 | P/E | N/A | |||
| Day Low | $0.85 | EPS | $-1.56 | |||
| Volume | 4,448,138 | |||||

